Published in

Wiley, American Journal of Hematology, 3(96), p. 330-337, 2021

DOI: 10.1002/ajh.26074

Links

Tools

Export citation

Search in Google Scholar

Outcomes with different administration schedules of Bortezomib in Bortezomib, Lenalidomide and dexamethasone ( VRd ) as first‐line therapy in Multiple Myeloma

Journal article published in 2020 by Joselle Cook ORCID, Isla Johnson, Alexandra Higgins ORCID, Surbhi Sidana ORCID, Rahma Warsame ORCID, Wilson Gonsalves ORCID, Morie A. Gertz ORCID, Francis Buadi, Martha Lacy, Prashant Kapoor, Angela Dispenzieri ORCID, Taxiarchis Kourelis ORCID, David Dingli, Pa Amie Fonder, Amie Fonder and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO